For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
Research Comparison
PT-141 and MT-2 are both melanocortin-receptor agonists, but with different selectivity. PT-141 is studied mainly for central MC3R/MC4R signaling, while MT-2 is an α-MSH analog studied across melanocortin receptors including MC1R.
| Attribute | PT-141 | MT-2 |
|---|---|---|
| Receptor focus | MC3R / MC4R | MC1R and broader melanocortin |
| Derivation | MT-2 metabolite | α-MSH analog |
| Research focus | Central neuroendocrine signaling | Melanocortin receptor pharmacology |
Yes — PT-141 is a metabolite of MT-2. Both are melanocortin-receptor agonists, but PT-141 is studied more selectively for MC3R/MC4R signaling.